Connection
Micol Rothman to Denosumab
This is a "connection" page, showing publications Micol Rothman has written about Denosumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.438 |
|
|
|
-
Kushchayeva Y, Kushchayev S, Dunn K, Pestun I, Rothman MS, Lewiecki EM. Bone Health ECHO Case Report: Significant Elevation in Bone Turnover Markers and Progression of Vertebral Fractures After Denosumab Discontinuation Followed by a PTH-Analog. J Clin Densitom. 2025 Jan-Mar; 28(1):101551.
Score: 0.231
-
Rothman MS, Olenginski TP, Stanciu I, Krohn K, Lewiecki EM. Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict. Osteoporos Int. 2019 Dec; 30(12):2401-2406.
Score: 0.160
-
Zaman A, Rothman MS, Billups SJ. Stop the denosumab delay! The effect of implementing an automatic reminder in the electronic medical record. Arch Osteoporos. 2022 01 20; 17(1):18.
Score: 0.047